Episode 2
Innovations in Type 1 Diabetes
Published on:
12th June, 2024
This episode of ACOFP's DO.fm Clinical podcast features Jay Shubrook, DO, FAAFP, FACOFP discussing Type 1 diabetes (T1D). We delve into the importance of screening and early intervention, the increasing prevalence in adults, the importance of patient-centered care and new and evolving technologies that are aiding in treatment and management of T1D.
Dr. Shubrook does disclose relationships with Abbott, Bayer and Novo Nordisk as a non-CE consultant and AstraZeneca, Eli Lilly and Novo Nordisk as an advisory board member. This podcast has been reviewed by non-conflicted physicians to ensure any potential conflicts are mitigated.
Mentioned in this episode: